GERN Jan 2025 4.500 put
| Previous close | 1.2000 |
| Open | 1.3000 |
| Bid | 1.2000 |
| Ask | 1.3500 |
| Strike | 4.50 |
| Expiry date | 2025-01-17 |
| Day's range | 1.2000 - 1.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 261 |
Business WireGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., May 16, 2024--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 2,910,780 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.
Insider MonkeyGeron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript
Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript May 2, 2024 Geron Corporation beats earnings expectations. Reported EPS is $-0.09178, expectations were $-0.1. Geron Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name […]
Simply Wall St.This Is Why Geron Corporation's (NASDAQ:GERN) CEO Compensation Looks Appropriate
Key Insights Geron to hold its Annual General Meeting on 9th of May Total pay for CEO Chip Scarlett includes US$787.0k...
